Literature DB >> 23161050

Bisphosphonate-related osteonecrosis of the jaw (BRONJ): 5 year experience in the treatment of 131 cases with ozone therapy.

A Agrillo1, F Filiaci, V Ramieri, E Riccardi, D Quarato, C Rinna, P Gennaro, F Cascino, V Mitro, C Ungari.   

Abstract

BACKGROUND: Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) are the result of the assumption of such drugs. The most widely used molecules are pamidronate and zoledronic acid, which are pyrophosphate analogues and are usually given to patient with bone remodelling diseases. International literature reports showed an association between this therapy and avascular necrosis, thus leading to review the guidelines for their administer. AIM: The authors present their protocol based upon medical treatment, antibiotic and antimycotic, together with minimally invasive surgery and ozone therapy developed after a 5 year experience to assess the viability of this treatment.
MATERIALS AND METHODS: In the last years researchers studied treatment protocols, both medical and surgical, for the management of BRONJ. Among these Ozone therapy is being adopted by several centers. From February 2004 and December 2010 a total number of 131 patients affected by BRONJ have been observed. Collected data include patients' age at the time of disorders, gender, presenting signs and symptoms, primary diagnosis, type and characteristics of the treatment performed, radiological findings and post-treatment results.
CONCLUSIONS: At the present time there are no major guidelines in international literature for the treatment of BRONJ, the Authors then propose a therapeutic protocol based upon minimally invasive surgery, antibiotic and anti mycotic therapy with the adoption of ozone as regenerating factor for tissues. In 90% of the cases the results confirmed the procedure with successful outcomes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23161050

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  19 in total

1.  Physician preferences for bone metastasis drug therapy in Canada.

Authors:  J Arellano; J M González; Y Qian; M Habib; A F Mohamed; F Gatta; A B Hauber; J Posner; N Califaretti; E Chow
Journal:  Curr Oncol       Date:  2015-10       Impact factor: 3.677

2.  Bisphosphonate-related osteonecrosis of jaws in advanced stage breast cancer was detected from bone scan: a case report.

Authors:  Prakasit Chirappapha; Saowanee Kitudomrat; Thanaporn Thongjood; Rangsima Aroonroch
Journal:  Gland Surg       Date:  2017-02

3.  The effects of ozone application on genotoxic damage and wound healing in bisphosphonate-applied human gingival fibroblast cells.

Authors:  Sıdıka Sinem Akdeniz; E Beyler; Y Korkmaz; E Yurtcu; U Ates; K Araz; F I Sahin; O Y Torun
Journal:  Clin Oral Investig       Date:  2017-07-11       Impact factor: 3.573

4.  Retrospective Analysis of Treatment Outcomes of Maxillary Sinusitis Associated with Medication-Related Osteonecrosis of the Jaw.

Authors:  Mitsunobu Otsuru; Saki Hayashida; Kota Morishita; Maho Murata; Sakiko Soutome; Miho Sasaki; Yukinori Takagi; Misa Sumi; Masahiro Umeda
Journal:  Int J Environ Res Public Health       Date:  2022-06-17       Impact factor: 4.614

5.  Stage-specific therapeutic strategies of medication-related osteonecrosis of the jaws: a systematic review and meta-analysis of the drug suspension protocol.

Authors:  Luca Ramaglia; Agostino Guida; Vincenzo Iorio-Siciliano; Alessandro Cuozzo; Andrea Blasi; Anton Sculean
Journal:  Clin Oral Investig       Date:  2018-01-13       Impact factor: 3.573

6.  Ozone Therapy in the Management of Persistent Radiation-Induced Rectal Bleeding in Prostate Cancer Patients.

Authors:  Bernardino Clavo; Norberto Santana-Rodriguez; Pedro Llontop; Dominga Gutierrez; Daniel Ceballos; Charlin Méndez; Gloria Rovira; Gerardo Suarez; Dolores Rey-Baltar; Laura Garcia-Cabrera; Gregorio Martínez-Sánchez; Dolores Fiuza
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-18       Impact factor: 2.629

Review 7.  Medication-Related Osteonecrosis of the Jaw: New Insights into Molecular Mechanisms and Cellular Therapeutic Approaches.

Authors:  Thomas Lombard; Virginie Neirinckx; Bernard Rogister; Yves Gilon; Sabine Wislet
Journal:  Stem Cells Int       Date:  2016-09-18       Impact factor: 5.443

8.  Treatment of medication-related osteonecrosis of the jaws (MRONJ) with ultrasonic piezoelectric bone surgery. A case series of 20 treated sites.

Authors:  Cornelio Blus; Giulio Giannelli; Serge Szmukler-Moncler; Germano Orru
Journal:  Oral Maxillofac Surg       Date:  2016-12-06

9.  Effect of Human Umbilical Cord Matrix-Derived Mesenchymal Stem Cells on Bisphosphonate-Related Osteonecrosis of the Jaw.

Authors:  Gwanghyun Yang; Young-Nam Kim; Hyunjeong Kim; Bu-Kyu Lee
Journal:  Tissue Eng Regen Med       Date:  2021-08-04       Impact factor: 4.451

10.  Increased growth factors play a role in wound healing promoted by noninvasive oxygen-ozone therapy in diabetic patients with foot ulcers.

Authors:  Jing Zhang; Meiping Guan; Cuihua Xie; Xiangrong Luo; Qian Zhang; Yaoming Xue
Journal:  Oxid Med Cell Longev       Date:  2014-06-24       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.